Adverse events associated with unblinded, but not with blinded, statin therapy in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid-Lowering Arm (ASCOT-LLA): a randomised double-blind placebo-controlled trial and its non-randomised non-blind exten (Q39037126)
Jump to navigation
Jump to search
scientific article published on 2 May 2017
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Adverse events associated with unblinded, but not with blinded, statin therapy in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid-Lowering Arm (ASCOT-LLA): a randomised double-blind placebo-controlled trial and its non-randomised non-blind exten |
scientific article published on 2 May 2017 |
Statements
1 reference
Adverse events associated with unblinded, but not with blinded, statin therapy in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid-Lowering Arm (ASCOT-LLA): a randomised double-blind placebo-controlled trial and its non-randomised non-blind exten (English)
1 reference
Ajay Gupta
Tim Collier
Bjorn Dahlof
Neil Poulter
Rory Collins
Peter Sever
ASCOT Investigators
2 May 2017
1 reference